EUVIMEDEUVIMED entdecken
Crossref

Carrier‐Free Activatable Nanomodulators for Cuproptosis‐Augmented Photoimmunotherapy of Colorectal Cancer

Xiaowen He, Chao Wang, Yuchen Ge, Pu Xu, Shaokun Yang, Wen Zhou, Rutian Li iD, Chen Xie iD, Quli Fan iD

Small · 09.11.2026

DOI: 10.1002/smll.76669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 09.11.2026. Verfasst von Xiaowen He und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, Nanjin…. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Key Program of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photoimmunotherapy (PIT) has emerged as a promising modality for colorectal cancer (CRC) treatment, yet it often suffers from limited response rates and immune escape. We herein report a carrier‐free, tumor‐specific nanomodulator (IRP@Cu‐R) for near‐infrared second window (NIR‐II) fluorescence imaging‐guided cuproptosis‐augmented PIT of CRC. IRP@Cu‐R is prepared by co‐assembly of IRP@Cu, which is synthesized by linking a NIR‐II fluorophore (IR820) with a photosensitizer (PPa) through Cu 2+ ‐chelated DTPA, and a boronic ester‐masked immune adjuvant (R848‐PB) without additional nanocarrier. The drug loading contents for PPa and R848‐PB are as high as 21.1% and 17.8%, respectively. With Cu 2+ coordinated, both NIR‐II fluorescence and photodynamic activity are quenched via photoinduced electron transfer (PeT). Upon exposure to endogenous hydrogen sulfide (H 2 S), Cu 2+ is converted to CuS, thereby restoring both activities. The released Cu 2+ is reduced to Cu + by glutathione (GSH), depleting antioxidants and inducing cuproptosis via lipoylated protein aggregation. Together with PDT, this process enhances immunogenic cell death. Meanwhile, excess H 2 O 2 cleaves the boronic ester bond of R848‐PB to release R848. These processes promote dendritic cell maturation, thereby eliciting potent systemic antitumor immunity against primary, distant and metastatic tumors. Thus, this study provides a generalizable carrier‐free strategy for integrating activatable NIR‐II fluorescence imaging with cuproptosis‐augmented photoimmunotherapy.

Schlagwörter

Stichwörter der Autor:innen

H2S activationNIR‐II fluorescence imagingcarrier‐free nanomedicinecolorectal cancercuproptosisphotoimmunotherapy

Autor:innen und Institutionen

  • State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, Nanjing, China.
  • The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

ORCID-Profile: Rutian Li, Chen Xie, Quli Fan

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • Key Program of the National Natural Science Foundation of China
  • Jiangsu Provincial Postgraduate Research Innovation Program
  • Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology
  • Synergetic Innovation Center for Organic Electronics and Information Displays
  • Basic Research Program of Jiangsu Province

Zitieren

APA

He, X., Wang, C., Ge, Y., Xu, P., Yang, S., Zhou, W., Li, R., Xie, C., & Fan, Q. (2026). Carrier‐Free Activatable Nanomodulators for Cuproptosis‐Augmented Photoimmunotherapy of Colorectal Cancer. Small. https://doi.org/10.1002/smll.76669

Vancouver

He X, Wang C, Ge Y, Xu P, Yang S, Zhou W, et al. Carrier‐Free Activatable Nanomodulators for Cuproptosis‐Augmented Photoimmunotherapy of Colorectal Cancer. Small. 2026. doi:10.1002/smll.76669

BibTeX
@article{He2026,
  author = {He, Xiaowen and Wang, Chao and Ge, Yuchen and Xu, Pu and Yang, Shaokun and Zhou, Wen and Li, Rutian and Xie, Chen and Fan, Quli},
  title = {Carrier‐Free Activatable Nanomodulators for Cuproptosis‐Augmented Photoimmunotherapy of Colorectal Cancer},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.76669}
}
Kostenlos starten →